India’s pharmaceutical market charged into 2026 with strong momentum, posting 11% YoY value growth to ₹20,836 crore in February, according to Pharmarack’s PharmaTrac Acquaint report. The moving annual total (MAT) reached ₹2.44 lakh crore, up 8.4%, propelled by price hikes (5.3%), new launches (3.5%), and volume gains (2.2%).[1][2][3] Therapy Leaders and Anti-Diabetic Dominance Cardiac held…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
